Cognitive Disorders

Simply put, we believe we are the most experienced CRO globally for preclinical cognition models and research; a claim that is backed up by the following:-

  • A management team that led and ran the disease area portfolios for Alzheimer’s Disease, Parkinson’s Disease and Schizophrenia within GSK Pharmaceuticals
  • Extensive Target class experience in cognition assays and and disease-relevant models
  • Technical Staff that have decades of experience of running the assays we utilise
  • State of the art technology
  • Translational endpoints and pharmacological validation.

Utilising both our UK and Irish laboratories, please follow the links below to the following categories of model that we offer. You may easily reference our models via the following quick links:-

By Disease Area

Pharmacological-deficit

Temporal-deficit

Age-induced/’Naturalistic’-deficit

Drug Combination – synergy or additivity

Preclinical
Pain
Inflammatory Pain
Neuropathic pain
Cognitive Disorders
Disease Area
Pharmacologica deficit
Temporal Deficit
Age induced
Drug Combination
Gastrointestinal Disorders
Sleep Disorders
Epilepsy
Depression & Anxiety
PK/PD studies
Schizophrenia
Molecular Biomarkers